← USPTO Patent Grants

Compositions for treating joint or connective tissue disease comprising dextran or poloxamer

Grant US12576105B2 Kind: B2 Mar 17, 2026

Assignee

MEDICINE PARK CO., LTD

Inventors

Yoo Sin Park, Il Hoon Lee

Abstract

Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.

CPC Classifications

A61K 31/765

Filing Date

2023-10-05

Application No.

18481694

Claims

20